BRUKER CORP - BRKR 6 3/8 09/01/28 (BRKRP) Stock Fundamental Analysis
USA - NASDAQ:BRKRP -
262.54 USD
+0.97 (+0.37%)
Taking everything into account, BRKRP scores 4 out of 10 in our fundamental rating. BRKRP was compared to 57 industry peers in the Life Sciences Tools & Services industry. There are concerns on the financial health of BRKRP while its profitability can be described as average. While showing a medium growth rate, BRKRP is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
In the past year BRKRP was profitable.
BRKRP had a positive operating cash flow in the past year.
In the past 5 years BRKRP has always been profitable.
BRKRP had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
BRKRP has a Return On Assets of 1.26%. This is in the better half of the industry: BRKRP outperforms 63.16% of its industry peers.
BRKRP has a better Return On Equity (4.41%) than 66.67% of its industry peers.
BRKRP has a better Return On Invested Capital (4.48%) than 66.67% of its industry peers.
The Average Return On Invested Capital over the past 3 years for BRKRP is significantly below the industry average of 14.79%.
The 3 year average ROIC (9.30%) for BRKRP is well above the current ROIC(4.48%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.26% | ||
| ROE | 4.41% | ||
| ROIC | 4.48% |
ROA(3y)6.74%
ROA(5y)6.6%
ROE(3y)21.33%
ROE(5y)21.26%
ROIC(3y)9.3%
ROIC(5y)9.28%
1.3 Margins
With a decent Profit Margin value of 2.31%, BRKRP is doing good in the industry, outperforming 63.16% of the companies in the same industry.
In the last couple of years the Profit Margin of BRKRP has declined.
The Operating Margin of BRKRP (9.69%) is better than 64.91% of its industry peers.
BRKRP's Operating Margin has declined in the last couple of years.
BRKRP has a Gross Margin (48.54%) which is comparable to the rest of the industry.
BRKRP's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.69% | ||
| PM (TTM) | 2.31% | ||
| GM | 48.54% |
OM growth 3Y-13.3%
OM growth 5Y-4.84%
PM growth 3Y-33.57%
PM growth 5Y-18.8%
GM growth 3Y-0.46%
GM growth 5Y0.54%
2. Health
2.1 Basic Checks
The number of shares outstanding for BRKRP has been increased compared to 1 year ago.
BRKRP has less shares outstanding than it did 5 years ago.
BRKRP has a worse debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 6.67 indicates that BRKRP is not in any danger for bankruptcy at the moment.
BRKRP's Altman-Z score of 6.67 is amongst the best of the industry. BRKRP outperforms 87.72% of its industry peers.
The Debt to FCF ratio of BRKRP is 49.40, which is on the high side as it means it would take BRKRP, 49.40 years of fcf income to pay off all of its debts.
BRKRP has a Debt to FCF ratio of 49.40. This is comparable to the rest of the industry: BRKRP outperforms 47.37% of its industry peers.
BRKRP has a Debt/Equity ratio of 1.32. This is a high value indicating a heavy dependency on external financing.
BRKRP has a worse Debt to Equity ratio (1.32) than 82.46% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.32 | ||
| Debt/FCF | 49.4 | ||
| Altman-Z | 6.67 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
A Current Ratio of 1.61 indicates that BRKRP should not have too much problems paying its short term obligations.
BRKRP's Current ratio of 1.61 is on the low side compared to the rest of the industry. BRKRP is outperformed by 71.93% of its industry peers.
BRKRP has a Quick Ratio of 1.61. This is a bad value and indicates that BRKRP is not financially healthy enough and could expect problems in meeting its short term obligations.
BRKRP has a Quick ratio of 0.68. This is amonst the worse of the industry: BRKRP underperforms 91.23% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.61 | ||
| Quick Ratio | 0.68 |
3. Growth
3.1 Past
BRKRP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -16.99%.
Measured over the past years, BRKRP shows a quite strong growth in Earnings Per Share. The EPS has been growing by 8.95% on average per year.
Looking at the last year, BRKRP shows a quite strong growth in Revenue. The Revenue has grown by 10.36% in the last year.
The Revenue has been growing by 10.19% on average over the past years. This is quite good.
EPS 1Y (TTM)-16.99%
EPS 3Y4.7%
EPS 5Y8.95%
EPS Q2Q%-38.46%
Revenue 1Y (TTM)10.36%
Revenue growth 3Y11.66%
Revenue growth 5Y10.19%
Sales Q2Q%-0.41%
3.2 Future
Based on estimates for the next years, BRKRP will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.50% on average per year.
The Revenue is expected to grow by 3.25% on average over the next years.
EPS Next Y-16.8%
EPS Next 2Y-0.61%
EPS Next 3Y5.98%
EPS Next 5Y9.5%
Revenue Next Year2.78%
Revenue Next 2Y2.24%
Revenue Next 3Y3.47%
Revenue Next 5Y3.25%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 122.11, the valuation of BRKRP can be described as expensive.
BRKRP's Price/Earnings ratio is in line with the industry average.
When comparing the Price/Earnings ratio of BRKRP to the average of the S&P500 Index (27.32), we can say BRKRP is valued expensively.
With a Price/Forward Earnings ratio of 110.28, BRKRP can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BRKRP is on the same level as its industry peers.
The average S&P500 Price/Forward Earnings ratio is at 22.89. BRKRP is valued rather expensively when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 122.11 | ||
| Fwd PE | 110.28 |
4.2 Price Multiples
BRKRP's Enterprise Value to EBITDA is on the same level as the industry average.
BRKRP's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 807.96 | ||
| EV/EBITDA | 77.53 |
4.3 Compensation for Growth
BRKRP has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)13.65
EPS Next 2Y-0.61%
EPS Next 3Y5.98%
5. Dividend
5.1 Amount
With a yearly dividend of 0.62%, BRKRP is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 0.55, BRKRP pays a better dividend. On top of this BRKRP pays more dividend than 94.74% of the companies listed in the same industry.
With a Dividend Yield of 0.62, BRKRP pays less dividend than the S&P500 average, which is at 2.42.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.62% |
5.2 History
The dividend of BRKRP has a limited annual growth rate of 4.81%.
BRKRP does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)4.81%
Div Incr YearsN/A
Div Non Decr YearsN/A
5.3 Sustainability
38.32% of the earnings are spent on dividend by BRKRP. This is a low number and sustainable payout ratio.
The dividend of BRKRP is growing, but earnings are growing more, so the dividend growth is sustainable.
DP38.32%
EPS Next 2Y-0.61%
EPS Next 3Y5.98%
BRUKER CORP - BRKR 6 3/8 09/01/28
NASDAQ:BRKRP (9/26/2025, 8:00:02 PM)
262.54
+0.97 (+0.37%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners84.43%
Inst Owner ChangeN/A
Ins Owners26.98%
Ins Owner ChangeN/A
Market Cap39.83B
Analysts76.19
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.62% |
Yearly Dividend0.2
Dividend Growth(5Y)4.81%
DP38.32%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-9.72%
Min EPS beat(2)-26.01%
Max EPS beat(2)6.57%
EPS beat(4)2
Avg EPS beat(4)-4.79%
Min EPS beat(4)-26.01%
Max EPS beat(4)6.57%
EPS beat(8)5
Avg EPS beat(8)2.53%
EPS beat(12)9
Avg EPS beat(12)4.53%
EPS beat(16)11
Avg EPS beat(16)6.67%
Revenue beat(2)1
Avg Revenue beat(2)-0.44%
Min Revenue beat(2)-3.65%
Max Revenue beat(2)2.76%
Revenue beat(4)1
Avg Revenue beat(4)-0.72%
Min Revenue beat(4)-3.65%
Max Revenue beat(4)2.76%
Revenue beat(8)3
Avg Revenue beat(8)-0.21%
Revenue beat(12)7
Avg Revenue beat(12)0.97%
Revenue beat(16)10
Avg Revenue beat(16)0.99%
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 122.11 | ||
| Fwd PE | 110.28 | ||
| P/S | 11.57 | ||
| P/FCF | 807.96 | ||
| P/OCF | 240.1 | ||
| P/B | 22.08 | ||
| P/tB | N/A | ||
| EV/EBITDA | 77.53 |
EPS(TTM)2.15
EY0.82%
EPS(NY)2.38
Fwd EY0.91%
FCF(TTM)0.32
FCFY0.12%
OCF(TTM)1.09
OCFY0.42%
SpS22.69
BVpS11.89
TBVpS-5.37
PEG (NY)N/A
PEG (5Y)13.65
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.26% | ||
| ROE | 4.41% | ||
| ROCE | 6.68% | ||
| ROIC | 4.48% | ||
| ROICexc | 4.57% | ||
| ROICexgc | 9.81% | ||
| OM | 9.69% | ||
| PM (TTM) | 2.31% | ||
| GM | 48.54% | ||
| FCFM | 1.43% |
ROA(3y)6.74%
ROA(5y)6.6%
ROE(3y)21.33%
ROE(5y)21.26%
ROIC(3y)9.3%
ROIC(5y)9.28%
ROICexc(3y)11.26%
ROICexc(5y)12.82%
ROICexgc(3y)18.89%
ROICexgc(5y)20.78%
ROCE(3y)13.86%
ROCE(5y)13.83%
ROICexcg growth 3Y-22.35%
ROICexcg growth 5Y-9.61%
ROICexc growth 3Y-31.42%
ROICexc growth 5Y-15.9%
OM growth 3Y-13.3%
OM growth 5Y-4.84%
PM growth 3Y-33.57%
PM growth 5Y-18.8%
GM growth 3Y-0.46%
GM growth 5Y0.54%
F-Score5
Asset Turnover0.54
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.32 | ||
| Debt/FCF | 49.4 | ||
| Debt/EBITDA | 4.37 | ||
| Cap/Depr | 55.42% | ||
| Cap/Sales | 3.39% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 30.5% | ||
| Profit Quality | 61.93% | ||
| Current Ratio | 1.61 | ||
| Quick Ratio | 0.68 | ||
| Altman-Z | 6.67 |
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)100.42%
Cap/Depr(5y)105.08%
Cap/Sales(3y)4.05%
Cap/Sales(5y)4.17%
Profit Quality(3y)75.38%
Profit Quality(5y)88.75%
High Growth Momentum
Growth
EPS 1Y (TTM)-16.99%
EPS 3Y4.7%
EPS 5Y8.95%
EPS Q2Q%-38.46%
EPS Next Y-16.8%
EPS Next 2Y-0.61%
EPS Next 3Y5.98%
EPS Next 5Y9.5%
Revenue 1Y (TTM)10.36%
Revenue growth 3Y11.66%
Revenue growth 5Y10.19%
Sales Q2Q%-0.41%
Revenue Next Year2.78%
Revenue Next 2Y2.24%
Revenue Next 3Y3.47%
Revenue Next 5Y3.25%
EBIT growth 1Y-20.95%
EBIT growth 3Y-3.19%
EBIT growth 5Y4.86%
EBIT Next Year15.58%
EBIT Next 3Y13.09%
EBIT Next 5Y8.93%
FCF growth 1Y-75.44%
FCF growth 3Y-10.61%
FCF growth 5Y-0.63%
OCF growth 1Y-51.42%
OCF growth 3Y-3.81%
OCF growth 5Y3.32%